NORPROLAC 0.025 MG Israel - English - Ministry of Health

norprolac 0.025 mg

ferring pharmaceuticals ltd - quinagolide as hydrochloride - tablets - quinagolide as hydrochloride 0.025 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).

NORPROLAC 0.05 MG Israel - English - Ministry of Health

norprolac 0.05 mg

ferring pharmaceuticals ltd - quinagolide as hydrochloride - tablets - quinagolide as hydrochloride 0.05 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).

NORPROLAC 0.075 MG TABLETS Israel - English - Ministry of Health

norprolac 0.075 mg tablets

ferring pharmaceuticals ltd - quinagolide as hydrochloride - tablets - quinagolide as hydrochloride 0.075 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).

NORPROLAC 0.15 MG TABLETS Israel - English - Ministry of Health

norprolac 0.15 mg tablets

ferring pharmaceuticals ltd - quinagolide as hydrochloride - tablets - quinagolide as hydrochloride 0.15 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).

Quinagolide 75microgram tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

quinagolide 75microgram tablets

aspire pharma ltd - quinagolide hydrochloride - oral tablet - 75microgram

Quinagolide 25microgram tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

quinagolide 25microgram tablets

aspire pharma ltd - quinagolide hydrochloride - oral tablet - 25microgram

Quinagolide 50microgram tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

quinagolide 50microgram tablets

aspire pharma ltd - quinagolide hydrochloride - oral tablet - 50microgram

Norprolac New Zealand - English - Medsafe (Medicines Safety Authority)

norprolac

pharmaco (nz) ltd - quinagolide hydrochloride 0.0273mg equivalent to 0.025 mg quinagolide; quinagolide hydrochloride 0.0546mg equivalent to 0.05 mg quinagolide - tablet - 3 x 25µg + 3 x 50µg - active: quinagolide hydrochloride 0.0273mg equivalent to 0.025 mg quinagolide excipient: colloidal silicon dioxide hypromellose iron oxide red as 2% tituration lactose monohydrate magnesium stearate maize starch microcrystalline cellulose active: quinagolide hydrochloride 0.0546mg equivalent to 0.05 mg quinagolide excipient: colloidal silicon dioxide hypromellose indigo carmine lactose monohydrate magnesium stearate maize starch microcrystalline cellulose - hyperprolactinaemia, with clinical manifestations as galactorrhoea, oligomenorrhoea, amenorrhoea, infertility or reduced libido.

Norprolac 25 µg - 50 µg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

norprolac 25 µg - 50 µg tabl.

ferring sa-nv - quinagolide hydrochloride 27,3 µg - eq. quinagolide 25 µg (light pink tablet); quinagolide hydrochloride 54,6 µg - eq. quinagolide 50 µg (light blue tablet) - tablet - 25 µg + 50 µg - quinagolide hydrochloride 27.3 µg; quinagolide hydrochloride 54.6 µg - quinagolide

NORPROLAC TABLET Canada - English - Health Canada

norprolac tablet

ferring inc - quinagolide (quinagolide hydrochloride) - tablet - 0.025mg - quinagolide (quinagolide hydrochloride) 0.025mg - miscellaneous therapeutic agents